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Helicobacter pylori infection results in diverse clinical conditions ranging from chronic gastritis and
ulceration to gastric adenocarcinoma. Among the multiethnic population of Malaysia, Indians consistently
have a higher H. pylori prevalence as compared with Chinese andMalays. Despite the high prevalence of H.
pylori, Indians have a relatively low incidence of peptic ulcer disease and gastric cancer. In contrast, gastric
cancer and peptic ulcer disease incidence is high in Chinese. H. pylori strains from Chinese strains
predominantly belong to the hspEAsia subpopulation while Indian/Malay strains mainly belong to the
hspIndia subpopulation. By comparing the genome of 27 Asian strains from different subpopulations, we
identified six genes associated with risk of H. pylori-induced peptic ulcer disease and gastric cancer. This
study serves as an important foundation for future studies aiming to understand the role of bacterial factors
in H. pylori-induced gastro-duodenal diseases.
H
elicobacter pylori contributes world-wide to various gastro-duodenal diseases ranging from chronic
gastritis to the development of peptic ulcer disease, gastric cancer (GC) andmucosa-associated lymphoid
tissue (MALT) lymphoma1,2. Significant variation exist in the prevalence and incidence of peptic ulcer
disease and gastric cancer due to infection withH. pylori among the different multiethnic populations inMalaysia
(Malays, Chinese and Indians)3,4. TheH. pylori prevalence amongst Indians is 35.6%, but the incidence of peptic
ulcer disease and gastric cancer is relatively low. Despite lowerH. pylori prevalence of 28.6% among the Chinese,
incidence of peptic ulcer disease and gastric cancer are relatively high3,5.
Phylogenetic analysis of the H. pylori genomes was carried out to determine the ancestry relationship among
the overall international isolates. Analysis of seven housekeeping genes of H. pylori by multi-locus sequence
typing (MLST) suggest that the bacteria originated in Africa and later split into seven distinct population groups
(hpEurope, hpNEAfrica, hpAfrica1, hpAfrica2, hpAsia2, hpSahul and hpEastAsia) and subpopulations that are
strongly associated with geographical localization. As for the subpopulations, AE1 and AE2 are within hpEurope,
hspWafrica and hspSAfrica within hpAfrica1, hspIndia within hpAsia2 and hspEAsia, hspAmerind and
hspMaori within the population of hpEastAsia6–8. In Malaysia, H. pylori hpAsia2/hspIndia mainly colonises
Indian and Malay subjects while hpEastAsia/hspEAsia predominantly colonises Chinese subjects. These two
groups (hpEastAsia/hspEAsia and hpAsia2/hspIndia) accounted for 41.5% and 39.0% of all H. pylori isolates
respectively6.
H. pylori genetic factors may play a role in influencing the disease outcome as Chinese strains from Malaysia
that are similar to strains from other areas of high gastric cancer incidence (Japan, Korea and China) predomi-
nantly belongs to hspEAsia subpopulation. Meanwhile, local Malay/Indian strains together with their counter-
parts from India (high H. pylori prevalence but low incidence of gastric cancer) belong to the hspIndia
subpopulation6. Besides H. pylori genetic factors, host and environmental factors may also influence disease
outcome.
InWestern countries, theH. pylori protein encoded by cytotoxin-associated gene A, CagA, has been shown to
be strongly associated with peptic ulcer disease, atrophic gastritis and gastric cancer1,9. However, cagA, carried by
almost all Asian H. pylori strains, does not predict disease outcome in this region of the world1,10,11. Previous
studies demonstrated that cagA containing the EPIYA-D tend to bemore virulent than those carrying the EPIYA-
C motif due to the higher level of IL-8 secretion produced by EPIYA-D strains as compared with EPIYA-C
strains12,13. Studies have proven that Cag-A containing the EPIYA-D motif possessed among the East Asian
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isolates has a stronger affinity for SHP-2 binding activity in contrast
with Western Cag-A. Thus, East Asian isolates are found to be
greater in countries with a high prevalence of gastric cancer12,14–19.
However, Schmidt et al. (2009) and other studies have demonstrated
that no association exists between EPIYA motifs and gastro-duo-
denal disease progression11,20,21. Thus, there is a need to discover
new virulence factors by studying the genomic makeup of Asian
strains.
H. pylori genetic diversity found in Malaysia, as demonstrated by
MLST typing, provides ideal conditions for studying the interaction
of co-existing H. pylori populations at the genomic level in a multi-
ethnic society. In this study, we analyzed H. pylori strains from
Asians (Malaysian Chinese, Malay, Indian), Japanese and mainland
Chinese subjects presenting with different disease status. The aim of
the study was to undertake whole genome comparative analysis of
these Asian strains to define a subset of H. pylori disease-associated
genes that may contribute to gastro-duodenal diseases.
Results
In this study, we carried out comparative genome analysis of 27 H.
pylori strains (4 gastric cancer, 10 peptic ulcer and 13 non-ulcer
dyspepsia strains). Strains were selected based on the phylogenetic
analysis construction using the full genome sequences (Figure 1).
Strains isolated from local Chinese subjects clustered closely with
hspEAsia strains from Japan (F30, F32 and F57), China (XZ274
and HLJ271) and Korea (HP51). Most strains from the local Malay
and Indian subjects (except UM037) were found clustered together
to form the hspIndia branch. Out of 27 genomes selected for com-
parative analysis, 21 were isolated from Malaysia, three from Japan,
two fromChina and one fromKorea (Table 1). The genomes of non-
Malaysian isolates were obtained fromGenBank. Comparative geno-
mic analysis revealed six genes that showed significant association
with peptic ulcer disease and/or gastric cancer (Table 2). Three genes
was associated with gastric cancer and the remaining 3 were assoc-
iated with both peptic ulcer disease and gastric cancer. All 6 genes
were statistically significantly correlated with disease with P-value
,0.05 when the percentage of identity were compared using
Student’s t-test (Table 3). Gene ontology and prediction of protein
families, domains and functional sites is presented in Table 4. Only
genes with predicted structure and functions were selected for fur-
ther analysis. The Pearson’s correlation coefficient test was per-
formed to evaluate the correlation between these genes and disease
status, as well as the correlation between different genes (Table 5).
Gastric Cancer. A 456 bp gene encoding for a H. pylori membrane
protein GC26_77 was absent in all (0/10) peptic ulcer disease (PUD)
strains analyzed. This gene was present in all gastric cancer (GC) (4/
4) and non-ulcer dyspepsia (NUD) (13/13) strains (Table 2). While
no significant statistical significance (P-value $ 0.05) was observed
between presence of this gene in strains isolated from GC and NUD
patients, the gene was absent in PUD patients (P-value , 0.001)
(Table 3). Pearson’s correlation also revealed a strong negative
correlation with PUD (Table 5).
Further, the presence of hypothetical ATPase protein GC26_69
was shown to correlate with strains isolated from GC patients. The
ATPase gene was detected in 100% (4/4) GC strains as compared
with 30% (3/10) of PUD strains and 0% (0/13) of isolates fromNUD.
Interestingly, the 3 isolates in which the hypothetical ATPase protein
GC26_69 gene was detected originated from PUD patients from
China, Japan and Korea. None of the PUD strains isolated from
Malaysia carried this gene (Table 2). Highly significant associations
were observed in the prevalence of this gene in isolates from GC
Figure 1 | Phylogenetic tree constructed on a whole genome of 33 H. pylori strains. Asian strains used in this study mostly clustered together with
hspIndia and hspEAsia strains according to host ethnicity (except UM037).
www.nature.com/scientificreports
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patients as compared with isolates from PUD and NUD (P-value
,0.001) (Table 3). The association of hypothetical ATPase protein
GC26_69 with GC was confirmed by a strong positive correlation by
Pearson’s analysis (Table 5).
In addition a hypothetical protein GC26_73 was detected in all (4/
4) GC strains but only 20% (2/10) and 7.7% (1/13) of PUD and NUD
strains respectively (Table 2). Comparison of the prevalence of this
gene in strains isolated from GC patients with that in both PUD and
NUDpatients showed a highly significant difference to exist (P-value
,0.001) (Table 3). The association of hypothetical protein GC26_73
with GC was confirmed by a strong Pearson’s positive correlation
(Table 5).
Peptic UlcerDisease andGastric Cancer.Genes encoding for theH.
pylori outer membrane protein GC26_66, phospho-2-dehydro-3-
deoxyheptonate aldolase, and hypothetical protein GC26_33 were
all highly associated with both GC and PUD strains. The gene
encoding for outer membrane protein GC26_66 being present in
all GC strains (4/4) and 90% (9/10) of the PUD strains. The outer
membrane protein gene was not detected in any of the six Chinese
NUD strains (Table 2). A highly statistically significant difference
was observed between the prevalence of outer membrane protein in
GC strains and Chinese NUD strains (P-value ,0.001) (Table 3).
While outer membrane protein GC26_66 was also present in NUD
strains from local Malay and Indians, alignment of the translated
protein sequence revealed that these local Malay and Indian strains
from NUD patients differed from GC/PUD strains in the 2nd to 5th
amino acid positions (Figure 2). For the purpose of discussion, we
will differentiate the former as type 1 and the later as type 2. Outer
membrane protein GC26_66 (type 1) was found to have strong
negative Pearson’s correlation with NUD (Table 5).
The phospho-2-dehydro-3-deoxyheptonate aldolase gene was
present in all of the GC strains (4/4) and 90% (9/10) of the PUD
strains. In contrast, this gene was only found in 15.4% (2/13) of the
NUD strains (Table 2). A statistically increased prevalence of this
gene was observed in isolates from GC patients as compared with
isolates fromNUD (P-value,0.001) (Table 3). Phospho-2-dehydro-
3-deoxyheptonate aldolase was also found to have strong negative
Pearson’s correlation with NUD (Table 5).
The gene encoding for hypothetical protein GC26_33 was present
in all GC strains (4/4). 60% (6/10) of the PUD strains and only 7.7%
(1/13) of the NUD strains (Table 2). Comparison of the prevalence of
this gene in H. pylori strains isolated from GC and PUD patients
showed a significantly increased prevalence (P-value,0.05) in those
patients with GC. Comparison of strains isolated fromGC and NUD
patients showed a significantly increased prevalence in isolates from
GC patients (P-value ,0.001) (Table 3). Hypothetical protein
GC26_33 was also found to have strong negative Pearson’s correla-
tion with NUD (Table 5).
Discussion
In this study, we identified six genes that were associated with H.
pylori-related disease status. In agreement with previous studies, no
singleH. pylori genetic marker on its own was shown to be associated
with any specific disease group22,23. However, it is possible that these
genes, working individually or collaborating with other genetic ele-
ments, are potential risk factors influencing the severity of disease or
disease progression. Based on Pearson’s analysis of the correlation
between disease status and genes, as well as the correlation between
different genes presented in Table 4, a correlation map was prepared
to summarize the relationship between disease and genes (Figure 3).
This map illustrates the complexity ofH. pylori factors that may affect
disease outcome. From the map, the number of genes that potentially
influence disease status appears to increase with severity of disease.
However, it should be noted that the correlation map only illustrates
the co-existence of genes but does not imply that these genes actually
interacts or work together to have an impact on disease development.
Based on our comparative genomic analysis, the presence of H.
pylori phospho-2-dehydro-3-deoxyheptonate aldolase in the absence
of membrane protein GC-26_77 was demonstrated to be a risk factor
for the development of peptic ulcer disease. In contrast, outer mem-
brane protein GC26_66 (type 1), hypothetical ATPase protein
Table 1 | Details of strains used in this study
Strain Ethnicity Age Gender Year of Isolation Geographical Disease Reference
GC26 Chinese 70 Female 2005 Malaysia Gastric cancer 30
F57 Japanese - - - Japan Gastric cancer 32
F32 Japanese - - - Japan Gastric cancer 32
XZ274 Tibetan - - - China Gastric cancer 33
UM023 Chinese 71 Female 2011 Malaysia Peptic ulcer disease 30
UM065 Chinese 57 Female 2011 Malaysia Peptic ulcer disease 30
UM066 Chinese 30 Female 2011 Malaysia Peptic ulcer disease 30
UM077 Chinese 59 Female 2011 Malaysia Peptic ulcer disease 30
UM067 Indian 64 Male 2011 Malaysia Peptic ulcer disease 30
UM084 Malay 60 Male 2011 Malaysia Peptic ulcer disease 30
UM114 Indian 42 Female 2012 Malaysia Peptic ulcer disease 30
F30 Japanese - - - Japan Peptic ulcer disease 32
HP51 Korean - - - Korea Peptic ulcer disease -
HLJ271 - - - - China Peptic ulcer disease 34
FD506 Chinese 56 Female 2005 Malaysia Non-ulcer dyspepsia 30
FD568 Chinese 50 Female 2005 Malaysia Non-ulcer dyspepsia 30
FD577 Chinese 67 Female 2005 Malaysia Non-ulcer dyspepsia 30
UM038 Chinese 73 Male 2011 Malaysia Non-ulcer dyspepsia 30
UM085 Chinese 68 Female 2011 Malaysia Non-ulcer dyspepsia 30
UM111 Chinese 76 Male 2012 Malaysia Non-ulcer dyspepsia 30
FD662 Malay 47 Female 2006 Malaysia Non-ulcer dyspepsia 30
FD719 Malay 60 Female 2006 Malaysia Non-ulcer dyspepsia 30
FD703 Malay 51 Male 2006 Malaysia Non-ulcer dyspepsia 30
FD423 Indian 39 Male 2005 Malaysia Non-ulcer dyspepsia 30
FD430 Indian 34 Male 2005 Malaysia Non-ulcer dyspepsia 30
FD535 Indian 44 Male 2005 Malaysia Non-ulcer dyspepsia 30
UM037 Indian 67 Female 2011 Malaysia Non-ulcer dyspepsia 30
www.nature.com/scientificreports
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GC26_69, hypothetical protein GC26_73 and hypothetical protein
GC26_33 were shown to be risk factors for gastric cancer develop-
ment. Outer membrane GC26_77 may have a protective effect
against peptic ulcer disease. However, these data were based on
bioinformatic analysis of strains fromMalaysia and few strains from
other parts of Asia. There is a need to validate these results experi-
mentally in the laboratory. Furthermore, it will be important to be
able screen and estimate the carriage rate of these genes in a larger
number of strains with different disease presentations from other
parts of Asia as well as other parts of the world.
H. pylori is an ancient and permanent resident of the human
stomach and has likely been part of the gastric microbiome since
the origin of human species. Given this, it is not surprising that more
than 80% of those infected with H. pylori remain asymptomatic. It
has been estimated that H. pylori-positive individuals have a 10 to
20% lifetime risk of developing peptic ulcer disease and a 1 to 2% risk
of developing gastric cancer24. While there is strong evidence to
support the role ofH. pylori in gastro-duodenal disease, there is some
evidence that the decline inH. pylori infection among human popu-
lations has been suggested to have contributed to the increase in
other diseases (e.g., esophageal adenocarcinoma [EAC], allergic
asthma, rhinitis and atrophy)25. Furthermore, it has been reported
that in adult males H. pylori colonization is associated with reduced
circulating leptin levels, a finding that may explain the observation
that significant weight gain may occur with H. pylori eradication26.
Furthermore, Blaser, M.J. and Atherton, J.C. have suggested that the
fall in H. pylori prevalence in developed countries may also contrib-
ute to high risk of metabolic syndrome, type II diabetes and meta-
bolic obesity27. Current literature would suggest that infection with
H. pylori is rapidly disappearing in developed countries28.
These risk factors can be potential biomarkers to identify those
strains that present with higher risk of developing severe gastro-
duodenal complications. The use of an approach where selective
eradication therapy is given to individuals with these risk genes
instead of all those infected with H. pylori will also help to preserve
the usual gut microbiota. The understanding of H. pylori genetic
factors and its association with severe gastro-duodenal diseases is
necessary to decide on the optimal management of H. pylori
infections.
A similar study has examined the genomic characteristics among
84 H. pylori isolates frm China with differing clinical status using
microarray29. In this study, regions associated with genes involved in
bacterial R-M systems and type IV secretion system were identified
to be linked to disease status. However, these genes were not iden-
tified in this study, instead, a different set of genes were identified in
this study. This inconsistency could be due to the different approach
adopted and the strains selected for these studies. The microarray
Table 3 | Significance of association of candidate genes with dis-
ease was examined by Student’s t-test
Genes/Function
Student’s t-test
(P-value)
GC vs.
PUD
GC vs.
NUD
Membrane Protein GC26_77 0.000** 0.390
Hypothetical ATPase Protein GC26_69 0.000** 0.000**
Hypothetical protein GC26_73 0.000** 0.000**
Outer membrane protein GC26_66 (type 1) 0.282 0.005**
Phospho-2-Dehydro-3-Deoxyheptonate
Aldolase
0.308 0.000**
Hypothetical protein GC26_33 0.022* 0.000**
*. P-value,0.05 is considered significant.
**. P-value ,0.01 is considered highly significant.
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was designed based on 6 sequenced strains of European and
American origins. Thus, genomic variations present only in Asian
strains but not in Western strains will not be identified using the
microarray approach. Although the next-generation sequencing
approach is not limited by probe design, it can be limited by the
quality of sequencing data. Also, the higher cost by the next-genera-
tion sequencing approach will also complicate mass screening of
large number of strains.
In summary, we have identified a number of H. pylori genetic
factors that may enable the identification of those at risk of peptic
ulcer disease strains and gastric cancer using a comparative genomic
approach. However, screening of a larger number ofH. pylori strains
from different disease groups is also required. Furthermore, it would
be of interest to investigate the functions of these largely hypothetical
proteins and how they interact to contribute to H. pylori-induced
pathogenesis.
Figure 2 | Sequence alignment of translated outer membrane protein GC26_66 gene. According to the translated peptide, sequences were grouped as
type 1 and type 2. Type 1 strains were GC26, F32, F57, XZ274, UM065, UM066, UM077, F30, HP51 and HLJ271. Type 2 strains were UM067, UM084,
UM114, FD662, FD703, FD719, FD423, FD430, FD535 and UM037. There was close correlation with host ethnicity.
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Methods
Sample background. Twenty-one H. pylori from Malaysia (GC26, UM023, UM065,
UM066, UM077, UM067, UM084, UM114, FD506, FD568, FD577, UM038, UM085,
UM111, FD662, FD719, FD703, FD423, FD430, FD535 and UM037) were isolated
from symptomatic patients undergoing endoscopy procedure at University ofMalaya
Medical Centre (UMMC, Kuala Lumpur, Malaysia) between the years 2007 and 2012
(Table 1). Based on endoscopic and histological examinations, patients were
diagnosed as having gastric cancer (GC), peptic ulcer disease (PUD) or non-ulcer
dyspepsia/functional dyspepsia (NUD/FD). All biopsies were obtained with the
informed consent of patients and approval of the Human Ethics Committees of
UMMC andUNSW. The genomes of the twenty-oneMalaysianH. pylori strains were
sequenced and assembled de novo as previously described30. For comparison, we
downloaded the genome sequences of another 6 Asian H. pylori strains from the
National Center for Biotechnology Information (NCBI) GenBank. Further
information of these strains are provided in Table 1. Only F30, F32, F57 andHP51 are
complete genomes, the rest are available as drafts.
Sequence Alignment and Phylogenetic Analysis. In addition to the 27 genomes
analyzed in this study, an additional of six strains regardless of East Asian origin was
downloaded from NCBI database resulting in a total of 33 strains that were used to
align with MAUVE (version 2.3.1) progressive alignment software and the output
data was viewed using the SplitsTree program (version 4.12.8) as Super Network.
Downstream analysis. Annotation of all twenty-seven H. pylori strains were
performed using the Rapid Annotation using Subsystem Technology (RAST) version
4.031. Comparative genomic analysis was performed using the sequence comparison
function available on the SEED viewer version 2.0. A List of core genes present among
all strains belonging to the same groupwas generated by SEED for each disease groups
(GC, PUD and NUD). FASTA file containing the sequences these of core genes were
generated for the respective disease groups. Further, RAST analysis was performed to
this data for annotation and comparing against other H. pylori strains in Table 1 to
obtain the percentage of similarity. The Student’s unpaired two-tailed t-test was
performed and the genes with P-values of , 0.05 and , 0.01were considered
statistically significant and highly significant respectively. Two-tailed Pearsons’
correlation analysis was adopted to examine for correlation between candidate genes
and disease, as well as between different genes.
Accession Numbers. The accession numbers of the H. pylori genome sequences
reported in this paper are: GC26 (AKHV00000000), UM023 (AUSK00000000),
UM065 (AUSM00000000), UM066 (AUSJ00000000 and CP005493), UM077
(AUSQ00000000), UM067 (AUSN00000000), UM084 (AUSO00000000), UM114
(AUSS00000000), FD506 (AKHO00000000), FD568 (AKHQ00000000), FD577
(AKHR00000000), UM038 (AUSL00000000), UM111 (AUSR00000000), FD662
(AKHT00000000), FD719 (AKHU00000000), FD703 (AKHS00000000), FD423
(AKHM00000000), FD430 (AKHN00000000), FD535 (AKHP00000000), UM037
(AUSI00000000 and CP005492), UM085 (AUSP00000000), F30 (AP011941), F32
Figure 3 | Correlationmap of candidate genes with disease states and between genes.The correlation was determined by Pearson’s correlation (Table 5).
Dotted line represents negative correlation and full line represents positive correlation. Bold line represents strong correlation with significance
,0.01 and fine line represents correlation with significance ,0.05. Genes outside the boxes represent genes present in the respective disease strains
(Student’s t-test) but no significant correlation with respective disease status (Pearson’s).
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(AP011943), F57 (AP011945), HP51 (CP000012), XZ274 (CP003419) and HLJ271
(ALKB00000000).
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